Proteome Changes Induced by Imatinib and Novel Imatinib Derivatives in K562 Human Chronic Myeloid Leukemia Cells-Reference-Cited by-同舟云学术

Proteome Changes Induced by Imatinib and Novel Imatinib Derivatives in K562 Human Chronic Myeloid Leukemia Cells

Published:2014-07-22 Issue:3 Volume:2 Page:363-381
ISSN:2227-7382
Container-title:Proteomes
language:en
Short-container-title:Proteomes

Author:

Arvaniti Katerina,Papadioti Anastasia,Kinigopoulou Maria,Theodorou Vassiliki,Skobridis Konstantinos,Tsiotis Georgios

Publisher

MDPI AG

Subject

Clinical Biochemistry,Molecular Biology,Biochemistry,Structural Biology

Link

http://www.mdpi.com/2227-7382/2/3/363/pdf

Reference46 articles.

1. Applying the discovery of the Philadelphia chromosome

2. The Biology of Chronic Myelogenous Leukemia: Implications for Imatinib Therapy

3. Chronic Myeloid Leukemia

4. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by supressing STAT5-dependent expression of Bcl-xL;Horita;J. Exp. Hematol.,2000

5. Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DDX3X Multifunctionally Modulates Tumor Progression and Serves as a Prognostic Indicator to Predict Cancer Outcomes;International Journal of Molecular Sciences;2019-12-31

2. Clinical biomarker discovery by SWATH-MS based label-free quantitative proteomics: impact of criteria for identification of differentiators and data normalization method;Journal of Translational Medicine;2019-05-31

3. Post-transcriptional regulation in hematopoiesis: RNA binding proteins take control;Biochemistry and Cell Biology;2019-02

4. An optimized approach in the synthesis of imatinib intermediates and analogues;RSC Advances;2016